Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamics results of a long‐acting C‐type natriuretic peptide prodrug, TransCon CNP

Author:

Breinholt Vibeke Miller1,Mygind Per Holse1,Christoffersen Eva Dam1,Zhang Ying2,Ota Sho2ORCID,Will Charlton R.2,Viuff Dorthe1

Affiliation:

1. Ascendis Pharma A/S Hellerup Denmark

2. Ascendis Pharma, Inc. Palo Alto CA USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Progress in managing children with achondroplasia;Expert Review of Endocrinology & Metabolism;2024-08-12

2. New treatments for children with achondroplasia;The Lancet Child & Adolescent Health;2024-04

3. The treatment of growth disorders in childhood and adolescence;Deutsches Ärzteblatt international;2024-02-09

4. C-Type Natriuretic Peptide Analogs: Current and Future Therapeutic Applications;Hormone Research in Paediatrics;2024-02-08

5. What Is the Role for Pediatric Endocrinologists in the Management of Skeletal Dysplasias?;The Journal of Clinical Endocrinology & Metabolism;2023-12-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3